| Filed | Form | Description | |
|---|---|---|---|
| 2/14/24 | SC 13G/A | SC 13G/A | → |
| 2/6/24 | SC 13G/A | AMENDMENT TO FORM SC 13G | → |
| 3/27/23 | SC 13G | SC 13G | → |
| 2/24/23 | SC 13D/A | AMENDMENT NO. 2 TO SCHEDULE 13D | → |
| 2/24/23 | SC 13D/A | AMENDMENT NO. 3 TO SCHEDULE 13D | → |
| 2/24/23 | SC 13D/A | AMENDMENT NO. 3 TO SCHEDULE 13D | → |
| ↓ | |||
CureVac is a biopharmaceutical company based in Tübingen, Germany that develops therapies based on messenger RNA (mRNA). With approximately 375 employees in 2018, it was founded in 2000 by Ingmar Hoerr, Steve Pascolo, Florian von der Mulbe, Günther Jung, and Hans-Georg Rammensee.